University of Washington Quality of Life subdomain outcomes after treatment of sinonasal malignancy: A prospective, multicenter study.
endoscopic sinus surgery
paranasal sinus diseases
patient reported outcome measure
postoperative
quality of life
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
17 Jun 2024
17 Jun 2024
Historique:
revised:
30
04
2024
received:
27
03
2024
accepted:
28
05
2024
medline:
17
6
2024
pubmed:
17
6
2024
entrez:
17
6
2024
Statut:
aheadofprint
Résumé
Sinonasal malignancies (SNMs) adversely impact patients' quality of life (QOL) and are frequently identified at an advanced stage. Because these tumors are rare, there are few studies that examine the specific QOL areas that are impacted. This knowledge would help improve the care of these patients. In this prospective, multi-institutional study, 273 patients with SNMs who underwent definitive treatment with curative intent were evaluated. We used the University of Washington Quality of Life (UWQOL) instrument over 5 years from diagnosis to identify demographic, treatment, and disease-related factors that influence each of the 12 UWQOL subdomains from baseline to 5 -years post-treatment. Multivariate models found endoscopic resection predicted improved pain (vs. nonsurgical treatment CI 2.4, 19.4, p = 0.01) and appearance versus open (CI 27.0, 35.0, p < 0.001) or combined (CI 10.4, 17.1, p < 0.001). Pterygopalatine fossa involvement predicted worse swallow (CI -10.8, -2.4, p = 0.01) and pain (CI -17.0, -4.0, p < 0.001). Neck dissection predicted worse swallow (CI -14.8, -2.8, p < 0.001), taste (CI -31.7, -1.5, p = 0.02), and salivary symptoms (CI -28.4, -8.6, p < 0.001). Maxillary involvement predicted worse chewing (CI 9.8, 33.2; p < 0.001) and speech (CI -21.8, -5.4, p < 0.001) relative to other sites. Advanced T stage predicted worse anxiety (CI -13.0, -2.0, p = 0.03). Surgical approach, management of cervical disease, tumor extent, and site of involvement impacted variable UWQOL symptom areas. Endoscopic resection predicted better pain, appearance, and chewing compared with open. These results may aid in counseling patients regarding potential QOL expectations in their SNM treatment and recovery course.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Natlie A. Cole-Reagins Foundation
Organisme : International Society of Inflammation and Allergy of the Nose
Organisme : UCLA Jonsson Comprehensive Cancer Center's Office of Cancer Training and Education
Informations de copyright
© 2024 The Author(s). International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.
Références
Abdou R, Baredes S. Population‐based results in the management of sinonasal and ventral skull base malignancies. Otolaryngol Clin North Am. 2017;50:481‐497.
Maoz SL, Wang EW, Hwang PH, et al. Long‐term quality of life after treatment in sinonasal malignancy: a prospective, multi‐center study. Int Forum Allergy Rhinol. 2023;13(11):2030‐2042. doi:10.1002/ALR.23171
Beswick DM, Holsinger FC, Kaplan MJ, et al. Design and rationale of a prospective, multi‐institutional registry for patients with sinonasal malignancy. Laryngoscope. 2016;126:1977‐1980.
Rogers SN, Lowe D, Yueh B, Weymuller EA. The physical function and social‐emotional function subscales of the University of Washington Quality of Life Questionnaire. Arch Otolaryngol Head Neck Surg. 2010;136:352‐357.
Deshields TL, Potter P, Olsen S, Liu J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer. 2014;22:1089‐1096.
Mahalingappa YB, Khalil HS. Sinonasal malignancy: presentation and outcomes. J Laryngol Otol. 2014;128:654‐657.
Fleseriu CM, Beswick DM, Maoz SL, et al. Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies. Int Forum Allergy Rhinol. 2023;14(4):775‐785. doi:10.1002/alr.23261
Jozaghi Y, Phan J, Hanna EY, Kupferman ME, Su SY. Functional outcomes and quality of life in patients with sinonasal, nasopharyngeal, and anterior skull base tumors. Curr Oncol Rep. 2022;24:775‐781.
Kuan EC, Wang EW, Adappa ND, et al. International consensus statement on allergy and rhinology: sinonasal tumors. Int Forum Allergy Rhinol. 2024;14:149‐608.
Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull‐base surgery. Int Forum Allergy Rhinol. 2019;9:S145‐S365.
Lowe D, Rogers SN. University of Washington Quality of Life questionnaire. Encyclopedia of Quality of Life and Well‐Being Research. 2012;0:1‐14.
Grimm DR, Beswick DM, Maoz SL, et al. SNOT‐22 subdomain outcomes following treatment for sinonasal malignancy: a prospective, multicenter study. Int Forum Allergy Rhinol. 2024.
Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. JNCI J Natl Cancer Inst. 2000;92:1422‐1429.
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long‐term, disease‐free survivors of breast cancer: a follow‐up study. JNCI J Natl Cancer Inst. 2002;94:39‐49.
Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Systematic review of change in bodily pain after sinus surgery. Otolaryngol‐Head Neck Surg. 2008;139:759‐765.
Woo HJ, Hwang PH, Kaplan MJ, Choby G. Clinical characteristics and prognostic factors of malignant tumors involving pterygopalatine fossa. Head Neck. 2020;42:281‐288.
Behairy EA, Barsem NG, Eldemerdash AA. Evaluation of surgical approaches to infratemporal and pterygopalatine fossae. Egypt. J Otolaryngol. 2023;39:109.
Gil Z, Fliss DM. Quality of life in patients with skull base tumors: current status and future challenges. Skull Base. 2010;20:11‐18.
Martinez‐Devesa P, Barnes ML, Alcock CJ, Kerr RSC, Milford CA. Evaluation of quality of life and psychiatric morbidity in patients with malignant tumours of the skull base. J Laryngol Otol. 2006;120:1049‐1054.
Ringash J, O'Sullivan B, Bezjak A, Redelmeier DA. Interpreting clinically significant changes in patient‐reported outcomes. Cancer. 2007;110:196‐202.
Pezdirec M, Strojan P, Boltezar IH. Swallowing disorders after treatment for head and neck cancer. Radiol Oncol. 2019;53:225‐230.
Asif M, Moore A, Yarom N, Popovtzer A. The effect of radiotherapy on taste sensation in head and neck cancer patients—a prospective study. Radiat Oncol. 2020;15:144.
El Ghani F, Van Den Brekel MW, De Goede CJ, Kuik J, Leemans CR, Smeele LE. Shoulder function and patient well‐being after various types of neck dissections. Clin Otolaryngol Allied Sci. 2002;27:403‐408.
Kuntz AL, Weymuller Jr EA. Impact of neck dissection on quality of life. Laryngoscope. 1999;109:1334‐1338.
Watkins JP, Williams GB, Mascioli AA, Wan JY, Samant S. Shoulder function in patients undergoing selective neck dissection with or without radiation and chemotherapy. Head Neck. 2011;33:615‐619.
Giordano L, Sarandria D, Fabiano B, Del Carro U, Bussi M. Shoulder function after selective and superselective neck dissections: clinical and functional outcomes. Acta Otorhinolaryngol Ital. 2012;32:376‐379.
Imai T, Sato Y, Abe J, et al. Shoulder function after neck dissection: assessment via a shoulder‐specific quality‐of‐life questionnaire and active shoulder abduction. Auris Nasus Larynx. 2021;48:138‐147.
Nipp RD, Greer JA, El‐Jawahri A, et al. Coping and prognostic awareness in patients with advanced cancer. J Clin Oncol. 2017;35:2551‐2557.
Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to health‐related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol. 2008;44:430‐438.